title: Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma.
abstract: Matrix metalloproteinase-9 (MMP-9) is hypothesized to facilitate leukocyte extravasation and extracellular remodeling in asthmatic airways. Careful descriptive studies have shown that MMP-9 levels are higher in the sputum of asthmatics; however, the consequence of increased MMP-9 activity has not been determined in this disease. We induced asthma in transgenic mice that express human MMP-9 in the murine lung tissue macrophage to determine the direct effect of human MMP-9 expression on airway inflammation. Transgenic (TG) and wild-type (WT) mice were immunized and challenged with ovalbumin. Forty-eight hours after the ovalbumin challenge, airway hyperresponsiveness (AHR) was measured, and inflammatory cell infiltration was evaluated in bronchoalveolar lavage fluid (BALF) and lung tissue. Baseline levels of inflammation were similar in the TG and WT groups of mice, and pulmonary eosinophilia was established in both groups by sensitization and challenge with ovalbumin. There was a significant reduction in AHR in sensitized and challenged trangenics compared with WT controls. Although total BALF cell counts were similar in both groups, the lymphocyte number in the lavage of the TG group was significantly diminished compared with the WT group (0.25 +/- 0.08 vs. 0.89 +/- 0.53; P = 0.0032). In addition, the draining lymphocytes were found to be larger in the TG animals compared with the WT mice. Equal numbers of macrophages, eosinophils, and neutrophils were seen in both groups. IL-13 levels were found to be lower in the sensitized TG compared with the WT mice. These results demonstrate an inverse relationship between human MMP-9 and AHR and suggest that MMP-9 expression alters leukocyte extravasation by reducing lymphocyte accumulation in the walls of asthmatic airways.
authors: Dept. of Medicine, Division of Pulmonary and Molecular Medicine, Columbia Presbyterian Medical Center, New York, NY 10032, USA.
authors: Divya
authors: D
authors: Mehra
authors: David I
authors: DI
authors: Sternberg
authors: Yuxia
authors: Y
authors: Jia
authors: Stephen
authors: S
authors: Canfield
authors: Vincent
authors: V
authors: Lemaitre
authors: Takwi
authors: T
authors: Nkyimbeng
authors: Julie
authors: J
authors: Wilder
authors: Joshua
authors: J
authors: Sonett
authors: Jeanine
authors: J
authors: D'Armiento
mesh_terms: D000818:Animals; D001249:Asthma / Q000139:chemically induced / Q000276:immunology*; D016535:Bronchial Hyperreactivity / Q000276:immunology*; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D017252:CD3 Complex / Q000276:immunology; D002465:Cell Movement / Q000276:immunology*; D016207:Cytokines / Q000276:immunology; D004195:Disease Models, Animal; D006801:Humans; D008198:Lymph Nodes / Q000276:immunology; D008214:Lymphocytes / Q000166:cytology / Q000276:immunology*; D020780:Matrix Metalloproteinase 9 / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D008822:Mice, Transgenic; D010047:Ovalbumin / Q000276:immunology / Q000494:pharmacology
chemical_list: D017252:CD3 Complex; D016207:Cytokines; D010047:Ovalbumin; D020780:Matrix Metalloproteinase 9